Skip to main content
logo
MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
4.010
+0.110 (2.82%)
Aug 6, 2026, 4:00 PM EDT - Market closed

MacroGenics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
157.08149.5149.9658.75151.9477.45
Revenue Growth
1.97%-0.31%155.26%-61.33%96.19%-26.16%
Gross Profit
116.94113.49137.6650.53144.5674.8
Operating Income
-63.66-72.84-110.58-168.24-121.42-202.8
Net Income
-70.36-74.62-66.97-9.06-119.76-202.12
Earnings Per Share
-1.10-1.18-1.07-0.15-1.95-3.37
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
154.23189.91201.67229.81154.35243.62
Total Debt
36.5136.7637.4633.9734.8325.47
Net Cash (Debt)
117.72153.15164.21195.83119.51218.15
Net Cash Growth
0.90%-6.73%-16.15%63.86%-45.21%-10.33%
Net Cash Per Share
1.862.422.623.161.953.64

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-69.96-81.04-68.37-78.21-86.96-143.83
Capital Expenditures
-1.73-1.91-3.71-1.76-3.62-6.2
Free Cash Flow
-71.69-82.95-72.08-79.97-90.58-150.03
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
74.45%75.91%91.80%86.00%95.14%96.58%
Operating Margin
-40.53%-48.72%-73.74%-286.38%-79.91%-261.85%
Pretax Margin
-21.81%-50.36%-44.03%-15.42%-78.82%-260.97%
Profit Margin
-21.38%-49.91%-44.66%-15.42%-78.82%-260.97%
FCF Margin
-45.64%-55.49%-48.06%-136.12%-59.62%-193.72%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-23.9623.9623.9623.9623.96
PS Ratio
1.620.681.3610.162.7112.70